BlackRock’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.5M | Sell |
2,732,623
-52,614
| -2% | -$702K | ﹤0.01% | 2598 |
|
|
2025
Q1 | $28.4M | Buy |
2,785,237
+55,959
| +2% | +$570K | ﹤0.01% | 2702 |
|
|
2024
Q4 | $43.2M | Buy |
2,729,278
+96,670
| +4% | +$1.53M | ﹤0.01% | 2511 |
|
|
2024
Q3 | $153M | Buy |
2,632,608
+119,364
| +5% | +$6.93M | ﹤0.01% | 1802 |
|
|
2024
Q2 | $115M | Buy |
2,513,244
+347,234
| +16% | +$15.9M | ﹤0.01% | 1932 |
|
|
2024
Q1 | $143M | Buy |
2,166,010
+129,222
| +6% | +$8.55M | ﹤0.01% | 1830 |
|
|
2023
Q4 | $81M | Buy |
2,036,788
+169,439
| +9% | +$6.74M | ﹤0.01% | 2171 |
|
|
2023
Q3 | $59.5M | Buy |
1,867,349
+122,952
| +7% | +$3.92M | ﹤0.01% | 2276 |
|
|
2023
Q2 | $70.1M | Buy |
1,744,397
+67,137
| +4% | +$2.7M | ﹤0.01% | 2248 |
|
|
2023
Q1 | $71.6M | Buy |
1,677,260
+38,934
| +2% | +$1.66M | ﹤0.01% | 2196 |
|
|
2022
Q4 | $78.7M | Buy |
1,638,326
+177,136
| +12% | +$8.51M | ﹤0.01% | 2156 |
|
|
2022
Q3 | $55M | Buy |
1,461,190
+64,847
| +5% | +$2.44M | ﹤0.01% | 2347 |
|
|
2022
Q2 | $38.6M | Buy |
1,396,343
+98,297
| +8% | +$2.72M | ﹤0.01% | 2627 |
|
|
2022
Q1 | $70.6M | Buy |
1,298,046
+11,520
| +0.9% | +$626K | ﹤0.01% | 2333 |
|
|
2021
Q4 | $75.3M | Buy |
1,286,526
+52,368
| +4% | +$3.06M | ﹤0.01% | 2365 |
|
|
2021
Q3 | $48.8M | Sell |
1,234,158
-5,215
| -0.4% | -$206K | ﹤0.01% | 2643 |
|
|
2021
Q2 | $52.6M | Buy |
1,239,373
+15,328
| +1% | +$651K | ﹤0.01% | 2629 |
|
|
2021
Q1 | $75.3M | Buy |
1,224,045
+24,844
| +2% | +$1.53M | ﹤0.01% | 2333 |
|
|
2020
Q4 | $84.6M | Buy |
1,199,201
+544,559
| +83% | +$38.4M | ﹤0.01% | 2142 |
|
|
2020
Q3 | $25.2M | Sell |
654,642
-5,679
| -0.9% | -$219K | ﹤0.01% | 2668 |
|
|
2020
Q2 | $24.8M | Buy |
+660,321
| New | +$24.8M | ﹤0.01% | 2643 |
|